bpc-157 topical vs injection The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety Injectable vs Oral BPC-157: What
Description
doi:10.1016/0049-3848(92)90030-e Fakhar H, Hashemi Tayer A
For healthy individuals without cancer risk factors, the theoretical concern remains speculative rather than demonstrated
From that point, the frequency drops to every other day for seven doses
The standard research protocol is 300 mcg per day, subcutaneous, administered in a fasted state, typically in the morning before food or exercise
Gradually increase your food intake but avoid sugar and starch for 3 weeks
